Gestational high saturated fat diet alters C57BL/6 mouse perinatal skeletal formation

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 86, Issue 5, 2009, Pages 362-369

  Liang, Chengya ^a   Oest, Megan E ^a   Jones, Jeryl C ^a   Prater, M Renee ^a,b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

C57BL 6 mice; Gestational high saturated fat diet; Perinatal skeletal formation

Indexed keywords

QUERCETIN; SATURATED FATTY ACID;

ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; CONCEPTION; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; INNER EAR; LABORATORY TEST; LIPID DIET; MACRONUTRIENT; MALE; MATERNAL BEHAVIOR; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETON; THREE DIMENSIONAL IMAGING;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CROWN-RUMP LENGTH; DIET, ATHEROGENIC; EMBRYO, MAMMALIAN; FATTY ACIDS; FEMALE; FETAL WEIGHT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; OSTEOGENESIS; OXIDATIVE STRESS; QUERCETIN; TOMOGRAPHY, X-RAY COMPUTED;

MUS;

EID: 70350732826     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20204     Document Type: Article

References (47)

1. Azuma Y, Oue Y, Kanatani H, Ohta T, Kiyoki M, Komoriya K. 1998. Effects of continuous alendronate treatment of bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats. J Pharm Exp Ther 286:128-135. (Pubitemid 28317983)
2. Barker DJ. 1995. The fetal and infant origins of disease. Eur J Clin Invest 25:457-463.
3. Barker DJ, Eriksson JG, Forsen T, Osmond C. 2002. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31:1235-1239. (Pubitemid 36204489)
4. Bertoli S, Striuli L, Testolin G, Cardinali S, Veggiotti P, Salvatori GC, Tagliabue A. 2002. [Nutritional status and bone mineral mass in children treated with ketogenic diet]. Recenti Prog Med 93:671-675.
5. Boots AW, Haenen GR, Bast A. 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325-337.
6. Chang TI, Horal M, Jain SK, Wang F, Patel R, Loeken MR. 2003. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 46:538-545. (Pubitemid 36577799)
7. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. 2004. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-kappa B. J Nutr 134:1013-1019.
8. 14C]glucose by postimplantation mouse embryos in vitro. J Embryol Exp Morphol 74:133-142.
9. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M. 2006. Review: developmental origins of osteoporotic fracture. Osteoporos Int 17:337-347.
10. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. 2005. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 135:2299-2304. (Pubitemid 41429581)
11. el-Hage S, Singh SM. 1990. Temporal expression of genes encoding free radical-metabolizing enzymes is associated with higher mRNA levels during in utero development in mice. Dev Genet 11:149-159.
12. Eriksson UJ, Borg LA. 1993. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes 42:411-419.
13. Eriksson UJ, Siman CM. 1996. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 45:1497-1502.
14. Fantel AG. 1996. Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 53:196-217. (Pubitemid 26190892)
15. Fiore G, Capasso A. 2008. Effects of vitamin E and C on placental oxidative stress: an in vitro evidence for the potential therapeutic or prophylactic treatment of preeclampsia. Med Chem 4:526-530.
16. Fleming A, Copp AJ. 1998. Embryonic folate metabolism and mouse neural tube defects. Science 280:2107-2109. (Pubitemid 28366201)
17. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ, Groner Y. 1995. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 173:1036-1041.
18. Harvey N, Cooper C. 2004. The developmental origins of osteoporotic fracture. J Br Menopause Soc 10:14-15, 29.
19. Heinze E, Vetter U. 1987. Skeletal growth of fetuses from streptozotocin diabetic rat mothers: in vivo and in vitro studies. Diabetologia 30:100-103. (Pubitemid 17035410)
20. Hester PY, Schreiweis MA, Orban JI, Mazzuco H, Kopka MN, Ledur MC, Moody DE. 2004. Assessing bone mineral density in vivo: dual energy X-ray absorptiometry. Poult Sci 83:215-221. (Pubitemid 39197282)
21. Horlick M, Wang J, Pierson Jr RN, Thornton JC. 2004. Prediction models for evaluation of total-body bone mass with dual-energy X-ray absorptiometry among children and adolescents. Pediatrics 114:e337-e345. (Pubitemid 41529500)
22. Jansson T, Powell TL. 2007. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113:1-13. (Pubitemid 47066020)
23. Kanter M, Altan MF, Donmez S, Ocakci A, Kartal ME. 2007. The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct 25:747-752. (Pubitemid 351202365)
24. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, Cetrulo CL, Theoharides TC. 2005. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 145:934-944. (Pubitemid 41129015)
25. Khong TY, De Wolf F, Robertson WB, Brosens I. 1986. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93:1049-1059. (Pubitemid 16004866)
26. Kim YJ, Bae YC, Suh KT, Jung JS. 2006. Quercetin, a flavonoid, inhibits proliferation and increases osteogenic differentiation in human adipose stromal cells. Biochem Pharmacol 72:1268-1278. (Pubitemid 44572193)
27. Lac G, Cavalie H, Ebal E, Michaux O. 2008. Effects of a high fat diet on bone of growing rats. Correlations between visceral fat, adiponectin and bone mass density. Lipids Health Dis 7:16.
28. Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS. 2009. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 296:E1210-E1229.
29. Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C. 1997. Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12-16.
30. Myatt L, Kossenjans W, Sahay R, Eis A, Brockman D. 2000. Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 9:79-82. (Pubitemid 30176218)
31. Neubert D, Peters H, Teske S, Kohler E, Barrach HJ. 1971. Studis on the problem of "aerobic glycolysis" occuring in mammalian embryos. Naunyn Schmiedebergs Arch Pharmakol 268:235-241.
32. Oest ME, Jones JC, Hatfield C, Prater MR. 2008. MicroCT evaluation of murine fetal skeletal development yields greater morphometric precision over traditional clear-staining methods. Birth Defects Res A Clin Mol Teratol 83:582-589.
33. Ornoy A. 2007. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy. Reprod Toxicol 24:31-41. (Pubitemid 47042350)
34. Patrick T, Roberts JM. 1999. Current concepts in preeclampsia. MCN Am J Matern Child Nurs 24:193-200.
35. Prater MR, Laudermilch CL, Holladay SD. 2006a. Does immune stimulation or antioxidant therapy reduce MNU-induced placental damage via activation of Jak-STAT and NFkappaB signaling pathways? Placenta 28:566-570.
36. Prater MR, Zimmerman KL, Pinn LC, Keay JM, Laudermilch CL, Holladay SD. 2006b. Role of maternal dietary antioxidant supplementation in murine placental and fetal limb development. Placenta 27:502-509.
37. Prater MR, Laudermilch CL, Liang C, Holladay SD. 2008. Placental oxidative stress alters expression of murine osteogenic genes and impairs fetal skeletal formation. Placenta 29:802-808.
38. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S. 2004. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67:1307-1313. (Pubitemid 38315096)
39. Schreiweis MA, Orban JI, Ledur MC, Hester PY. 2003. The use of densitometry to detect differences in bone mineral density and content of live White Leghorns fed varying levels of dietary calcium. Poult Sci 82:1292-1301.
40. Scifres CM, Nelson DM. 2009. Intrauterine growth restriction, human placental development and trophoblast cell death. J Physiol 587:3453-3458.
41. Schweizer S, Hattendorf B, Schneider P, Aeschlimann B, Gauckler L, Muller R, Gunther DX. 2007. Preparation and characterization of calibration standards for bone density determination by microcomputed tomography. Analyst 132:1040-1045. (Pubitemid 47479678)
42. Sharova LV, Sharov AA, Sura P, Gogal RM, Smith BJ, Holladay SD. 2003. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis? Int Immunopharmacol 3:945-955.
43. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, Borenstein M. 1996. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 175:793-799. (Pubitemid 26357931)
44. Smith EE, Ferguson VL, Simske SJ, Gayles EC, Pagliassotti MJ. 2000. Effects of high fat or high sucrose diets on rat femora mechanical and compositional properties. Biomed Sci Instrum 36:385-390.
45. Ward WE, Kim S, Robert Bruce W. 2003. A western-style diet reduces bone mass and biomechanical bone strength to a greater extent in male compared with female rats during development. Br J Nutr 90:589-595. (Pubitemid 37168358)
46. Wentzel P, Eriksson UJ. 1998. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47:677-684. (Pubitemid 28160461)
47. Yang X, Borg LA, Eriksson UJ. 1997. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272:E173-E180. (Pubitemid 127749981)